"The World's Leading Journal of Real-Time Intelligence & Sponsored Bulletins"
The Economic Times ·
Gland Pharma shares rose 3.89% after reporting strong Q2 FY27 results, with revenue growing 23% and net profit jumping 58% year-on-year. The stock touched a 52-week high of Rs 3,345, supported by robust CDMO growth, improved margins, new product launches and increased US regulatory approvals.
Extending his Deepavali greetings over the weekend, Mr. Kharge told reporters that Deepavali is a major festival celebrated by everyone in India and described it as 'khushiyon ka Eid'
Anadolu’s recap of top stories from around the globe
Of the 257 fire calls, at least 24 were crackers related, said Delhi Fire Service; there were 42 burn related patients admitted at AIIMS on Deepavali
The Tupolev Tu-154M, which departed from a military base near Moscow, has been on the US sanctions list since 2023.
KFCC writes to CBFC pointing out that last-minute title changes will impose financial burden on producers, as fixing a title early is essential for promoting movies from pre-production stage
Chipmaker's stock slips 4.2% on Robinhood platform following internal investigation into admitted affair, reports say
From bereavement to stillbirth, more women are finding release in rage rooms from Bath to Swindon.
New rules allowing cell towers up to 20 metres high to be built without resource consent have upset some homeowners around the country. It follows amendments to the Resource Management Act and are intended to remove blackouts. Under the previous rules, towers in residential areas could be built up…
Fetching news dispatch…
Sources, branding, conversations, and advertising.